Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma. Read more about Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.
Re-defining response and treatment effects for neuro-oncology immunotherapy clinical trials. Read more about Re-defining response and treatment effects for neuro-oncology immunotherapy clinical trials.
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. Read more about Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study. Read more about Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study.
Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab. Read more about Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab.
Familial gliomas: cases in two pairs of brothers. Read more about Familial gliomas: cases in two pairs of brothers.
Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas. Read more about Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas.
Pure germinomas of the central nervous system: treatment strategies and outcomes. Read more about Pure germinomas of the central nervous system: treatment strategies and outcomes.
Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria). Read more about Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria).
Effects of adjuvant chemotherapy and radiation on overall survival in children with choroid plexus carcinoma. Read more about Effects of adjuvant chemotherapy and radiation on overall survival in children with choroid plexus carcinoma.
